‘Killed it on the spot': Infant bites cobra to death after it coiled around his hands
The one-year-old boy, identified only by his first name Govinda, bit the cobra while he was playing at his home in the small town of Bettiah near the Indo-Nepal border, according to local news reports.
"When we saw the snake in the child's hand, everyone rushed towards him, but in the meantime, he already bit the snake, killing it on the spot," the child's grandmother told local news.
After biting the snake, the boy fainted and was rushed to a primary health care centre for initial treatment, after which he was taken to the town's Government Medical College Hospital (GMCH).
'The boy, Govind Kumar, was referred here yesterday by the primary health centre close to his village where he was rushed by family members after he fainted soon after chewing on the live snake,' hospital superintendent Duvakant Mishra told Indian Express.
The venom's effects were reportedly mild, only knocking the boy unconscious, but not fatal.
"Timely treatment saved Govinda's life," Saurabh Kumar, a doctor of the government hospital, told the Times of India.
"The child's condition is currently stable and treatment is being administered under the supervision of doctors. The medical team is treating the child, providing continuous medication, and he is under observation,' Dr Kumar said.
Govinda reportedly is being closely monitored at GMCH Bettiah with treatment for poisoning expected to start if he started showing any symptoms, according to local news reports.
India has around 300 species of snakes, including 60 highly venomous snakes such as the Russell's vipers, kraits, and the saw-scaled viper, which are responsible for most of the bite-related deaths.
The Indian cobra completes this list of the "big four" species responsible for the most snakebites in India.
The country recorded over a million snake bite deaths in just two decades from 2000-19, according to a study published in 2020 in the journal eLife.
More than two-thirds of the recorded deaths came from eight of India's 28 states, including Bihar, Jharkhand, Madhya Pradesh, Odisha and Uttar Pradesh.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
a day ago
- Yahoo
The #1 Spice for Gut Health, According to Gastroenterologists
Reviewed by Dietitian Emily Lachtrupp, M.S., RDKey Points Gut health influences inflammation, disease risk and overall health. Turmeric may help improve gut health by reducing inflammation and improving the microbiome. Also include plenty of plants and fermented foods for a healthy the world of wellness trends, there's no denying that gut health has gained immense popularity. Terms like probiotics, good bacteria and microbiome have become part of our common vocabulary. The increased focus is well-deserved, as a rapidly growing body of research shows that gut health is connected to almost every other aspect of our overall health. Keeping your gut healthy involves eating a varied, balanced diet that includes lots of fruits, vegetables, whole grains, nuts, seeds, lean protein and fermented foods like yogurt and kimchi. And be sure to take a look at the spices in your pantry. Not only do herbs and spices add flavor, but they are also packed with nutrients that can support your gut-health goals. To get you started, we asked gut-health experts for their thoughts on the top spice for gut health—both said turmeric. Why Turmeric Is So Great for Gut Health When asked, both gastroenterologists recommend turmeric, a colorful and warming spice that can fit into just about any meal. Here's why. 'Turmeric is a relative of ginger that has a warm, slightly bitter flavor and a bold orange color that gets showcased in Indian and Southeast Asian food. But beyond its culinary uses, turmeric is known for its potential health benefits due to the active ingredient curcumin, which has anti-inflammatory properties,' says Will Bulsiewicz, M.D., a board-certified gastroenterologist. One catch with turmeric is that curcumin is poorly absorbed by the body. There is a workaround for this, though, and it is adding black pepper when you eat turmeric. According to Bulsiewicz, a compound in black pepper called piperine increases curcumin's bioavailability, allowing your body to absorb it better. Here are the two main reasons turmeric is GI docs' top spice for gut health. It May Support a Healthier Gut Microbiome Research has found that the relationship between turmeric's curcumin and your microbiome is a two-way street. First, curcumin helps maintain a positive balance of beneficial bacteria in the gut. Second, all that 'good' gut bacteria breaks down the curcumin to create antioxidant and anti-inflammatory compounds, which support your gut and overall health. It Might Reduce Inflammation Ground turmeric has a golden hue, while fresh turmeric is a bright orange. Foods with rich, deep colors like this contain high amounts of polyphenols. These compounds found in fruits, vegetables, herbs and spices offer potential health benefits. For example, polyphenols may help lower inflammation, and they also have antioxidant properties that neutralize cell-damaging free radicals. Turmeric has been associated with lower levels of inflammation in research, thanks in large part to its polyphenol content. 'Studies have shown that curcumin can help promote a healthy gut microbiome, reduce inflammation in the digestive tract and alleviate symptoms of digestive disorders like irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD),' says Ritu Nahar, M.D., a board-certified gastroenterologist. Most current research on the effects that curcumin from turmeric may have on IBS has focused on supplements versus food. It's important to note that the amount of curcumin in an extract will far exceed what's found in food. However, the results are promising. For example, a review of nine studies found that when participants took a supplement with curcumin or turmeric extract, their IBS symptoms (particularly abdominal pain) and quality of life improved. Benefits of a Healthy Gut While the primary purpose of your digestive system (or 'gut') is to process food, the influence of the gut is far-reaching. Your gut plays an active role in everything from immunity and mood to your weight and the quality of your sleep. A healthy gut microbiome is also important for disease prevention and management, including a potential reduced risk of cardiovascular diseases and diabetes. Keeping your gut in tip-top shape is all about balance. There are trillions of bacteria living in the gut, which are collectively known as the gut microbiome. Within that microbiome, there are good and bad bacteria. Prioritizing healthy diet and lifestyle habits helps the number of good bacteria outweigh the bad and maintains diversity in those bacteria, both of which are needed for gut health. Other Strategies to Improve Gut Health If you are looking for more ways to support your gut health, Bulsiewicz and Nahar provided some suggestions to get you started. Eat More Plants It's probably no surprise that eating more plant foods is at the top of this list. Fruits, vegetables, whole grains, seeds, nuts and legumes are rich in soluble fiber and resistant starches, which our gut bacteria metabolize to create a short-chain fatty acid called butyrate. 'Butyrate has a number of beneficial effects on our gut bacteria, on our gut barrier, on our immune system and throughout our entire body," says Bulsiewicz. "In short, if there were one thing that I would want more of for gut health, it would be butyrate.' Manage Stress There's a strong connection between the gut and brain. And it's thought that chronic stress can negatively impact gut health over time by reducing beneficial bacteria and increasing inflammation and intestinal permeability, also known as leaky gut syndrome. Nahar recommends practicing stress-reducing techniques such as yoga, meditation and deep-breathing or diaphragmatic-breathing exercises, and states that doing so may help balance the nervous system and support healthy digestion. Focus on Hydration Besides inadequate fiber intake, a common culprit for digestive woes is dehydration. Adequate hydration helps your digestive system work properly by softening stool and supporting the mucosal lining of the intestines. If you often reach for carbonated beverages to meet your hydration goals, stick to moderation. Nahar explains they may cause aerophagia, or essentially the problem of swallowing too much air. 'The main symptom of this is excessive flatulence and bloating,' says Nahar. Include Prebiotics and Probiotics If you're looking to support a diverse and thriving gut microbiome, you'll want to reach for the 'biotic' foods. The more well-known of the two is probiotics, which are live microorganisms in fermented foods like yogurt, kefir and sauerkraut that may boost your microbiome's diversity. Prebiotics will help feed the beneficial bacteria in your gut and are found in foods like garlic, onion, bananas and many other whole grains, legumes, fruits and vegetables. Our Expert Take Eating a diverse diet that includes plenty of plant foods like fruits, vegetables and whole grains will help keep your gut microbiome happy and thriving. Be sure to include some herbs and spices in your meals to maximize your gut health. We recommend incorporating more turmeric with black pepper in your meals to boost the number of good gut microbes in your digestive system and tamp down inflammation. Read the original article on EATINGWELL
Yahoo
2 days ago
- Yahoo
Human Papilloma Virus Testing Market Research Report 2025-2033 Featuring Abbott Laboratories, BioMerieux, Bio-Rad Laboratories, Epigenomics, Siemens Healthineers, Hologic, Qiagen, F. Hoffmann-La Roche
The Human Papillomavirus (HPV) Testing Market is projected to grow from USD 1.52 billion in 2024 to USD 3.62 billion by 2033, at a 10.11% CAGR from 2025. This growth is fueled by increased cervical cancer awareness, robust screening programs, and advancements in diagnostic technologies. HPV, a significant sexually transmitted infection, plays a critical role in cervical and other cancers, highlighting the importance of early detection through testing. Global initiatives, especially in developed nations, have embraced HPV-based screenings, driving demand. However, challenges such as limited access and high technology costs in low-income countries remain. Notable market segments include consumables, immunodiagnostics, and PCR testing. Key regions like the U.S., France, India, and Saudi Arabia see varied growth based on governmental support, awareness, and infrastructure. Human Papilloma Virus Testing Market Dublin, July 29, 2025 (GLOBE NEWSWIRE) -- The "Human Papilloma Virus Testing Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033" report has been added to Human papillomavirus (HPV) Testing Market was USD 1.52 billion in 2024 and is expected to reach USD 3.62 billion by 2033, with a CAGR of 10.11% from 2025 to 2033. The growth is due to increasing awareness of cervical cancer, increased screening programs, and technological advancements in diagnostic technologies in global healthcare systems. Internationally, the use of HPV testing is increasing with growing awareness regarding prevention of cervical cancer, government-sponsored screening programs, and WHO's initiative to eliminate cervical cancer as a public health issue. Developed countries have embraced HPV-based screening on a large scale, and developing nations are also adopting it, with the support of global health programs. Its high sensitivity and long-term risk prediction make it a method of choice in contemporary gynecological Driver in the Human Papilloma Virus (HPV) Testing Market Increasing Awareness and Government Screening ProgramsInternational awareness programs and country-level screening programs have increased demand for HPV testing to a large extent. Governments in developed and emerging economies are adopting routine cervical cancer screening guidelines for women aged 30 and older. WHO organizations advocate for HPV testing as a key tool for early detection of cancer. Greater awareness of HPV-associated cancers and immunization also reinforces demand. These efforts account for early diagnosis, prompt intervention, and overall reduction in HPV-associated disease burden, thus driving the market forward. SEP 2024, The United States, Australia, India, and Japan are rolling out a key initiative to fight cervical cancer across the Indo-Pacific, a preventable disease which is a significant health crisis in the region. This initiative is part of larger announcements made during the Quad Leaders Breakthroughs in HPV TestingInnovation in diagnostic methods - like PCR, next-generation sequencing, and self-sampling kits - has revolutionized HPV testing by enhancing accuracy, accessibility, and convenience. Automated platforms, multiplex assays, and liquid-based cytology enable quicker turnaround times and large-scale screening. These technologies are particularly precious in resource-poor settings and enable wider adoption in public health systems. Ongoing R&D spending by diagnostic firms serves to improve test sensitivity and affordability, fueling additional market growth. June 2023, The WHO has prequalified a fourth test for human papillomavirus (HPV). Although most HPV infections will clear on their own, a few of the higher-risk types can cause cervical cancer, so HPV testing is important for cervical cancer Prevalence of HPV-Associated Cancers Growing global incidence of HPV-related cancers, particularly cervical cancer, is a strong market driver. Cervical cancer is the fourth leading female cancer in the world according to the WHO, and the overwhelming majority of cases are caused by high-risk HPV types. Growing cases of cancer have driven the need for early detection strategies, putting HPV testing at the center of preventive medicine. As healthcare professionals and patients strive for surefire diagnostic measures, HPV testing is also becoming a necessity in women's health care. An estimated 47,984 new cases of cancer occur each year in the United States in areas of the body where human papillomavirus (HPV) commonly in the Human Papilloma Virus (HPV) Testing Market Limited Access in Low-Income CountriesIn spite of worldwide awareness, HPV testing is not readily available in low- and middle-income countries because of a lack of healthcare infrastructure and resources. There are few laboratory facilities, skilled professionals, and regular screening programs in most areas. Cultural taboo and sexual stigma also discourage HPV testing participation. This inequality avoids early diagnosis and enhances the risk of cervical cancer at advanced stages. It is essential to overcome these barriers using cost-effective point-of-care diagnostics and education initiatives for equitable market Cost of Sophisticated HPV Testing TechnologiesThe price of advanced HPV testing technologies, including PCR-based platforms and DNA sequencing, can be out of reach for healthcare systems and some patients. As developed nations implement these technologies into regular screening, the affordability gap restricts accessibility in resource-scarce settings. In addition, maintenance costs, quality assurance, and specialized staff requirements contribute to higher operating costs for clinics and laboratories. This cost factor hinders mass screening activities, particularly in developing countries. Key Players Analyzed: Overview, Key Persons, Recent Development & Strategies, Financial Insights Abbott Laboratories BioMerieux SA Bio-Rad Laboratories, Inc. Epigenomics AG Siemens Healthineers AG Hologic Inc Qiagen NV F. Hoffmann-La Roche Ltd Key Attributes: Report Attribute Details No. of Pages 200 Forecast Period 2024 - 2033 Estimated Market Value (USD) in 2024 $1.52 Billion Forecasted Market Value (USD) by 2033 $3.62 Billion Compound Annual Growth Rate 10.1% Regions Covered Global Key Topics Covered: 1. Introduction2. Research Methodology2.1 Data Source2.1.1 Primary Sources2.1.2 Secondary Sources2.2 Research Approach2.2.1 Top-Down Approach2.2.2 Bottom-Up Approach2.3 Forecast Projection Methodology3. Executive Summary4. Market Dynamics4.1 Growth Drivers4.2 Challenges5. Human Papilloma Virus Testing Market5.1 Historical Market Trends5.2 Market Forecast6. Human Papilloma Virus Testing Market Share Analysis6.1 By Application6.2 By Product6.3 By Technology6.4 By End Use6.5 By Countries7. Application7.1 Cervical Cancer Screening7.2 Vaginal Cancer Screening8. Product8.1 Consumables8.2 Instruments8.3 Services9. Technology9.1 Polymerase chain reaction (PCR)9.2 Liquid-based cytology9.3 Immunodiagnostics9.4 Hybrid Capture9.5 Others10. End Use10.1 Hospitals & Clinics10.2 Laboratories10.3 Others11. Countries11.1 North America11.1.1 United States11.1.2 Canada11.2 Europe11.2.1 France11.2.2 Germany11.2.3 Italy11.2.4 Spain11.2.5 United Kingdom11.2.6 Belgium11.2.7 Netherlands11.2.8 Turkey11.3 Asia-Pacific11.3.1 China11.3.2 Japan11.3.3 India11.3.4 South Korea11.3.5 Thailand11.3.6 Malaysia11.3.7 Indonesia11.3.8 Australia11.3.9 New Zealand11.4 Latin America11.4.1 Brazil11.4.2 Mexico11.4.3 Argentina11.5 Middle East & Africa11.5.1 Saudi Arabia11.5.2 UAE11.5.3 South Africa12. Porter's Five Forces Analysis12.1 Bargaining Power of Buyers12.2 Bargaining Power of Suppliers12.3 Degree of Rivalry12.4 Threat of New Entrants12.5 Threat of Substitutes13. SWOT Analysis13.1 Strength13.2 Weakness13.3 Opportunity13.4 Threat 14. Key Players Analysis For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Attachment Human Papilloma Virus Testing Market CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
Yahoo
2 days ago
- Yahoo
Human Papilloma Virus Testing Market Research Report 2025-2033 Featuring Abbott Laboratories, BioMerieux, Bio-Rad Laboratories, Epigenomics, Siemens Healthineers, Hologic, Qiagen, F. Hoffmann-La Roche
The Human Papillomavirus (HPV) Testing Market is projected to grow from USD 1.52 billion in 2024 to USD 3.62 billion by 2033, at a 10.11% CAGR from 2025. This growth is fueled by increased cervical cancer awareness, robust screening programs, and advancements in diagnostic technologies. HPV, a significant sexually transmitted infection, plays a critical role in cervical and other cancers, highlighting the importance of early detection through testing. Global initiatives, especially in developed nations, have embraced HPV-based screenings, driving demand. However, challenges such as limited access and high technology costs in low-income countries remain. Notable market segments include consumables, immunodiagnostics, and PCR testing. Key regions like the U.S., France, India, and Saudi Arabia see varied growth based on governmental support, awareness, and infrastructure. Human Papilloma Virus Testing Market Dublin, July 29, 2025 (GLOBE NEWSWIRE) -- The "Human Papilloma Virus Testing Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033" report has been added to Human papillomavirus (HPV) Testing Market was USD 1.52 billion in 2024 and is expected to reach USD 3.62 billion by 2033, with a CAGR of 10.11% from 2025 to 2033. The growth is due to increasing awareness of cervical cancer, increased screening programs, and technological advancements in diagnostic technologies in global healthcare systems. Internationally, the use of HPV testing is increasing with growing awareness regarding prevention of cervical cancer, government-sponsored screening programs, and WHO's initiative to eliminate cervical cancer as a public health issue. Developed countries have embraced HPV-based screening on a large scale, and developing nations are also adopting it, with the support of global health programs. Its high sensitivity and long-term risk prediction make it a method of choice in contemporary gynecological Driver in the Human Papilloma Virus (HPV) Testing Market Increasing Awareness and Government Screening ProgramsInternational awareness programs and country-level screening programs have increased demand for HPV testing to a large extent. Governments in developed and emerging economies are adopting routine cervical cancer screening guidelines for women aged 30 and older. WHO organizations advocate for HPV testing as a key tool for early detection of cancer. Greater awareness of HPV-associated cancers and immunization also reinforces demand. These efforts account for early diagnosis, prompt intervention, and overall reduction in HPV-associated disease burden, thus driving the market forward. SEP 2024, The United States, Australia, India, and Japan are rolling out a key initiative to fight cervical cancer across the Indo-Pacific, a preventable disease which is a significant health crisis in the region. This initiative is part of larger announcements made during the Quad Leaders Breakthroughs in HPV TestingInnovation in diagnostic methods - like PCR, next-generation sequencing, and self-sampling kits - has revolutionized HPV testing by enhancing accuracy, accessibility, and convenience. Automated platforms, multiplex assays, and liquid-based cytology enable quicker turnaround times and large-scale screening. These technologies are particularly precious in resource-poor settings and enable wider adoption in public health systems. Ongoing R&D spending by diagnostic firms serves to improve test sensitivity and affordability, fueling additional market growth. June 2023, The WHO has prequalified a fourth test for human papillomavirus (HPV). Although most HPV infections will clear on their own, a few of the higher-risk types can cause cervical cancer, so HPV testing is important for cervical cancer Prevalence of HPV-Associated Cancers Growing global incidence of HPV-related cancers, particularly cervical cancer, is a strong market driver. Cervical cancer is the fourth leading female cancer in the world according to the WHO, and the overwhelming majority of cases are caused by high-risk HPV types. Growing cases of cancer have driven the need for early detection strategies, putting HPV testing at the center of preventive medicine. As healthcare professionals and patients strive for surefire diagnostic measures, HPV testing is also becoming a necessity in women's health care. An estimated 47,984 new cases of cancer occur each year in the United States in areas of the body where human papillomavirus (HPV) commonly in the Human Papilloma Virus (HPV) Testing Market Limited Access in Low-Income CountriesIn spite of worldwide awareness, HPV testing is not readily available in low- and middle-income countries because of a lack of healthcare infrastructure and resources. There are few laboratory facilities, skilled professionals, and regular screening programs in most areas. Cultural taboo and sexual stigma also discourage HPV testing participation. This inequality avoids early diagnosis and enhances the risk of cervical cancer at advanced stages. It is essential to overcome these barriers using cost-effective point-of-care diagnostics and education initiatives for equitable market Cost of Sophisticated HPV Testing TechnologiesThe price of advanced HPV testing technologies, including PCR-based platforms and DNA sequencing, can be out of reach for healthcare systems and some patients. As developed nations implement these technologies into regular screening, the affordability gap restricts accessibility in resource-scarce settings. In addition, maintenance costs, quality assurance, and specialized staff requirements contribute to higher operating costs for clinics and laboratories. This cost factor hinders mass screening activities, particularly in developing countries. Key Players Analyzed: Overview, Key Persons, Recent Development & Strategies, Financial Insights Abbott Laboratories BioMerieux SA Bio-Rad Laboratories, Inc. Epigenomics AG Siemens Healthineers AG Hologic Inc Qiagen NV F. Hoffmann-La Roche Ltd Key Attributes: Report Attribute Details No. of Pages 200 Forecast Period 2024 - 2033 Estimated Market Value (USD) in 2024 $1.52 Billion Forecasted Market Value (USD) by 2033 $3.62 Billion Compound Annual Growth Rate 10.1% Regions Covered Global Key Topics Covered: 1. Introduction2. Research Methodology2.1 Data Source2.1.1 Primary Sources2.1.2 Secondary Sources2.2 Research Approach2.2.1 Top-Down Approach2.2.2 Bottom-Up Approach2.3 Forecast Projection Methodology3. Executive Summary4. Market Dynamics4.1 Growth Drivers4.2 Challenges5. Human Papilloma Virus Testing Market5.1 Historical Market Trends5.2 Market Forecast6. Human Papilloma Virus Testing Market Share Analysis6.1 By Application6.2 By Product6.3 By Technology6.4 By End Use6.5 By Countries7. Application7.1 Cervical Cancer Screening7.2 Vaginal Cancer Screening8. Product8.1 Consumables8.2 Instruments8.3 Services9. Technology9.1 Polymerase chain reaction (PCR)9.2 Liquid-based cytology9.3 Immunodiagnostics9.4 Hybrid Capture9.5 Others10. End Use10.1 Hospitals & Clinics10.2 Laboratories10.3 Others11. Countries11.1 North America11.1.1 United States11.1.2 Canada11.2 Europe11.2.1 France11.2.2 Germany11.2.3 Italy11.2.4 Spain11.2.5 United Kingdom11.2.6 Belgium11.2.7 Netherlands11.2.8 Turkey11.3 Asia-Pacific11.3.1 China11.3.2 Japan11.3.3 India11.3.4 South Korea11.3.5 Thailand11.3.6 Malaysia11.3.7 Indonesia11.3.8 Australia11.3.9 New Zealand11.4 Latin America11.4.1 Brazil11.4.2 Mexico11.4.3 Argentina11.5 Middle East & Africa11.5.1 Saudi Arabia11.5.2 UAE11.5.3 South Africa12. Porter's Five Forces Analysis12.1 Bargaining Power of Buyers12.2 Bargaining Power of Suppliers12.3 Degree of Rivalry12.4 Threat of New Entrants12.5 Threat of Substitutes13. SWOT Analysis13.1 Strength13.2 Weakness13.3 Opportunity13.4 Threat 14. Key Players Analysis For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Attachment Human Papilloma Virus Testing Market CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900Melden Sie sich an, um Ihr Portfolio aufzurufen.